Progyny (PGNY) Price to Sales (2019 - 2026)

Progyny (PGNY) has reported Price to Sales for 8 consecutive years, with 6.37 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales rose 12.09% year-over-year to 6.37 in Q2 2026; TTM through Jun 2026 was 1.7, a 11.83% increase from a year earlier, with the FY2025 full-year figure at 1.66, up 31.77% from the prior year.
• Price to Sales was 6.37 for Q2 2026 at Progyny, up from 4.05 in the prior quarter.
• Over five years, Price to Sales peaked at 27.38 in Q1 2022 and troughed at 4.05 in Q1 2026.
• A 5-year average of 10.43 and a median of 10.07 in 2024 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales plunged 66.54% in 2022 and jumped 36.35% in 2025, its largest moves.
• Over 5 years, Price to Sales stood at 13.56 in 2022, then declined by 2.14% to 13.27 in 2023, then sank by 62.84% to 4.93 in 2024, then jumped by 36.35% to 6.72 in 2025, then decreased by 5.33% to 6.37 in 2026.
• The last three Price to Sales figures came in at 6.37 (Q2 2026), 4.05 (Q1 2026), and 6.72 (Q4 2025), per Business Quant data.